CISS Q3 2025 Earnings Negative EPS and Significant Stock Decline DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus IMVT Q1 2026 Earnings WiderThanExpected Loss as Clinical Development Advances ALAB Q1 2026 Earnings Strong EPS Beat Signals Robust Demand for AI Connectivity Solutions ORCL Q1 2026 Earnings EPS Beats Estimates Amid Strong Cloud Momentum BNR Q3 2022 Earnings Narrower Loss Surpasses Estimates Stock Declines